middle.news
INOVIQ Unveils Breakthrough Ovarian Cancer Test with Perfect Early Detection
11:43pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
INOVIQ Unveils Breakthrough Ovarian Cancer Test with Perfect Early Detection
11:43pm on Monday 2nd of June, 2025 AEST
Key Points
EXO-OC™ test shows 77% sensitivity and 99.6% specificity across all ovarian cancer stages
Perfect detection of all early-stage (I and II) ovarian cancers with zero missed cases
Test uses proprietary exosome isolation combined with AI-enhanced biomarker analysis
Australian provisional patent filed to protect intellectual property
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Inoviq (ASX:IIQ)
OPEN ARTICLE